Michael Carulli
Net worth: 89 356 $ as of 2026-08-30
Net worth: 89 356 $ as of 2026-08-30
Michael Carulli is currently Chief Financial Officer at PMV Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Carulli was Executive Director-R&D Financial Planning at Bristol Myers Squibb Co. Mr. Carulli earned an MBA from Fordham University and completed undergraduate studies at Siena College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-04 | 73,848 ( 0.14% ) | 89 356 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director of Finance/CFO | 2024-01-04 |
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Siena College
Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Select your edition
All financial news and data tailored to specific country editions